Investment Institute
Annual Outlook

Equity Outlook – Thriving in the mist

  • 30 November 2023 (7 min read)

Key points

  • 2023 was an unusual period for equity markets, which made gains despite sharp interest rates rises. However, only a handful of stocks drove these gains
  • As we expect rates to remain high, we believe quality should be considered over the duration of securities
  • The question of ‘who’s right’ between GDP and earnings consensus has to be solved, and one of these two projections is likely to be wrong

There is no doubt that 2023 was a year for the textbooks. Low economic growth, high inflation and hawkish central banks were not enough to moderate overall equity market gains. Instead, this trio’s momentum supported the asset class.

But 2023’s performance should be taken with a pinch of salt, as it was largely attributable to a few large-cap stocks. The top 10% of companies ranked by market capitalisation gained 17%, compared with just 3% for the rest. But this divergence in returns between the component stocks of the global index is not abnormal, as evidenced by the below-average level of dispersion (Exhibit 1).

In the future, dispersion could settle higher in the context of higher interest rates. In such a scenario, the equity risk premium would be lower, creating a higher hurdle rate for companies, so active management should overtake passive.

Exhibit 1: Super dispersion

Image

Throughout the course of the year, real global GDP growth expectations have steadily been revised higher, offering support to upward earnings revisions. Although global profits have declined, companies surprised on the upside thanks to the resilience of profit margins.

Interest rate volatility was clearly one of the determining factors of equity market performance. As inflation fell, however, central banks began to halt their tightening cycles. This has been reflected in a performance driven by the multiple expansions in global equity markets, which is at odds with the rise in interest rates.

In our central scenario where growth remains sluggish but a recession is avoided, inflation heads back towards its target and central banks broadly start to reverse course in the second half of the year. We believe that global equities should generate a positive return with some volatility likely reflecting the precise timing of when central banks reverse course.


High for longer

Uncertainties over the short and long ends of US interest rate curves were one of the highlights of the year. These uncertainties were explained for the short end by the constant revision of the expected peak rate until mid-year and then the scale of cuts thereafter, while apparent reassessment of the 'neutral rate' mainly occurring in the second half of the year helped explain higher term rates.

Exhibit 2: Long duration did well despite higher interest rates

 

Image

There is still uncertainty about the exact timing of the rate cut, but markets are counting on a change towards the end of the first half of 2024 – our own view is for the first cut to be delivered in June 2024. But investors are more convinced rates will stabilise at higher levels for longer, and this convergence of views should mitigate long-term interest rate risks for equities.

Yet the impact of rising interest rates on equities has not been observed in the usual way. Long duration stocks did not fall significantly (Exhibit 2). Instead, those names outperformed the rest of the market and, for instance, value (+2.5%) has underperformed growth (+25.6%).

How do we explain this? The rise in real rates has been uneven – the first half of the year saw real rates remain fairly stable; they then rose by around 80 basis points (bp) from late June. This has been a determining factor in the relative performance of growth versus value (first half: +20.5%, second: +1.8%).

Additionally, it is important to note that, at present, long-duration companies generally have relatively sound balance sheets. Currently, the information technology (IT) sector is the least leveraged, unlike in the past. As a result, equity investors have rewarded these quality stocks regardless of their valuation.

For 2024, we believe the market will continue to favour low-leverage stocks. Also, reaching a new range in long-term rates would suggest less volatility in interest rates, which would improve growth stocks’ forward earnings visibility. This is why a barbell allocation to IT (benefiting from lower rate volatility) and financials (benefiting from structurally higher rates) looks reasonable.


Sluggish growth outlook

At the global level, analysts have consistently and significantly upgraded their 2024 forecasts for earnings growth expecting +11% while consensus GDP forecasts have declined to +2.6% from +3.1% (Exhibit 3). This discrepancy has resulted in an inconsistent relationship between earnings and GDP.

Exhibit 3: The market and macro at odds

Image

The resilience in earnings-per-share has been largely attributed to resilient margins. However, we expect this resilience to fade in 2024, after positive surprises of the results published by companies this year. With pressure from slowing inflation (lower pricing), tight financial conditions and still increasing wage growth, the profit margin could evolve at a below trend pace next year. This suggests a fall in consensus margin expectations of the order of at least 150/300 percentage points for Europe and US market constituents respectively.

Yet this margin contraction alone would not be sufficient to bring earnings growth in line with our 2024 GDP growth forecasts. To achieve this, sales would also require a sizeable downward revision, as the consensus is for +5% in the US and +2.6% in Europe. Such a scenario would push multiples even higher, prompting a greater potential of correction in share prices, although we should not ignore the chance of an upward adjustment in economic growth, as we have seen this year.

If economic growth was to be revised up in 2024, we would prefer exposure to the US than to the rest of the world as historically, upward revisions of US GDP forecasts have been a catalyst for forward US outperformance versus global equities.

To get in on this theme, we think that a long position on US cyclicals, which are currently cheap, would be a judicious move. On a relative basis, we are cautious on emerging markets cyclicals given the uncertainty surrounding the Chinese economic situation.

Exhibit 4: Japan is at the right spot

Image

From a broader perspective, we believe Japan can continue to outperform its peers on a purely macro relative basis. Firstly, we expect Japan to deliver above-trend GDP growth and below-target inflation, which is the best combination for equities. Second, it has the second largest equity risk premium across countries and, finally, we see the lowest market price elasticity to tighter financial conditions (Exhibit 4). Insofar as the study is conducted in local terms, the risk of the yen appreciating could erode the returns for international investors.

This last point is not the least important, since credit defaults, fiscal consolidation and higher minimum rates of return could undoubtedly feed a tighter financial condition trend which should be a clear risk to monitor for the equity market.

Beware the merchants of doom
Macroeconomics Annual Outlook

Beware the merchants of doom

Investment Institute
Insurance investment outlook 2024: Catching opportunities across the risk spectrum
Macroeconomics Annual Outlook

Insurance investment outlook 2024: Catching opportunities across the risk spectrum

  • by Arnaud Lebreton, Amaury Boyenval
  • 06 December 2023 (10 min read)
Investment Institute
Rates Outlook – The year of bonds redux
Macroeconomics Annual Outlook

Rates Outlook – The year of bonds redux

  • by Alessandro Tentori
  • 30 November 2023 (7 min read)
Investment Institute
UK Outlook – Lags could push Bank of England to faster cuts
Macroeconomics Annual Outlook

UK Outlook – Lags could push Bank of England to faster cuts

  • by David Page
  • 30 November 2023 (5 min read)
Investment Institute

    Disclaimer

    This website is published by AXA Investment Managers Asia (Singapore) Ltd. (Registration No. 199001714W) for general circulation and informational purposes only. It does not constitute investment research or financial analysis relating to transactions in financial instruments, nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities. It has been prepared without taking into account the specific personal circumstances, investment objectives, financial situation or particular needs of any particular person and may be subject to change without notice. Please consult your financial or other professional advisers before making any investment decision.

    Due to its simplification, this publication is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this publication is provided based on our state of knowledge at the time of creation of this publication. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    All investment involves risk, including the loss of capital. The value of investments and the income from them can fluctuate and investors may not get back the amount originally invested. Past performance is not necessarily indicative of future performance.

    Some of the Services and/or products may not be available for offer to retail investors.

    This publication has not been reviewed by the Monetary Authority of Singapore.